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identification of Tfh cells. Just as the useof
FoxP3 has revolutionized the delineation
of Treg cells, the use of Bcl-6 as a molec-
ular marker will undoubtedly facilitate the
study of Tfh cells.
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In this issue of Immunity, Andrews et al. (2009) used single-molecule fluorescence microscopy to demon-
strate that the IgE receptor Fc3RI in the plasma membrane can signal in a mobile state.For several decades, there has been a
passionate interest among immunologists
to understand the molecular mechanisms
bywhich immuno tyrosine activationmotif
(ITAM)-containing receptors such as Fc
receptor, T cell receptor (TCR), and B
cell receptor (BCR) transduce signals.
These signaling processes are of central
importance in understanding many
immune functions. In more recent years,
advances in imaging technologies have
revolutionalized our thinking about these
signaling processes. These live-imaging
techniques have revealed a very dynamic
picture of signaling. They have demon-
strated an importance of compartmen-
talization, membrane microdomains,
receptor diffusion and/or transport, the
role of cytoskeleton, receptor scaffolds,
and endocytosis as different dynamic
processes that regulate different stages
of signaling (Dustin, 2009). Studies on
the TCR and BCR have revealed the
formation of the immune synapse and mi-
croclusters as sites of signal initiation
(Dustin, 2009). These studies, consistent452 Immunity 31, September 18, 2009 ª200with previous work on IgE receptors,
have revealed a hierarchy of receptor
assemblies showing inverse correlation
between sizes of complex and signaling
(Seagrave et al., 1991). However, one
common insight that has emerged out of
these studies is that immobilization of
ligand-engaged receptors is strongly
correlated with the ability of these recep-
tors to signal (Varma, 2008). Therefore,
most models of signaling have relied on
kinetic parameters of receptor-ligand
interactions that facilitate receptor immo-
bilization. In this issue of Immunity, An-
drews et al. (2009) use single-molecule
fluorescence microscopy of quantum
dot (QD)-labeled receptors to demon-
strate that signaling occurs when recep-
tors are mobile.
Signaling via the high-affinity IgE recep-
tor Fc3RI is initiated when IgE-engaged Fc
receptors are crosslinked via antigen. In
the earliest steps of signaling, Fc3RIb and
Fc3RIg are phosphorylated by Lyn kinase.
The phosphorylated Fc3RIg can now
recruit Syk family kinases and initiate9 Elsevier Inc.downstreamsignaling tocalciummobiliza-
tion and Ras and/or MAP-kinase pathway
activation, which leads to downstream
responses such as degranulation and cy-
tokine production. For over three decades,
the relationship between diffusion and
signaling for IgE receptors has been exten-
sively studied by numerous groups using
different biophysical approaches (Hol-
owka and Baird, 1996). Most groups
arrived at the conclusion that receptor
immobilization is correlated with initiation
of a degranulation response. However,
early studies showed that making sig-
naling-competent small signaling clusters
didnotcausemarked receptor immobiliza-
tion, but creating larger signaling com-
plexes that would inhibit signaling did
(Mendoza and Metzger, 1976; Schles-
singer et al., 1976). Studies by Menon
et al. (1986) arrived at the conclusion that
by making dimeric anti-IgE complexes,
there was poor degranulation associated
with a lack of receptor immobilization.
Hence, there was a need to address this
issuewith a sensitive technique that allows
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Figure 1. Hierarchy of Diffusion Behavior
Shown are relative diffusion coefficients of different kinds of antigens used by Andrews et al. in this issue
of Immunity. Signaling complexes initiated by single antigen molecules exhibit substantial diffusion
(DNP2-BSA, DNP4-BSA, DNP12-BSA, DNP-Strep-QD, and 0.001–0.01 mg/ml of DNP25-BSA); however,
larger complexes generated by higher concentrations of DNP25-BSA undergo arrest. These experiments
reveal a hierarchy of diffusion behavior that correlates directly with size of complexes formed.one to track engaged receptors at different
valencies and antigen concentrations and
correlate it with signaling. The current
study by Andrews et al. (2009) uses
single-molecule tracking of Fc receptors
engaged by QD-labeled IgE or antigen
and demonstrates that at low antigen
concentrations at which robust degranula-
tion is observed, one can observe sub-
stantial diffusion of engaged receptors.
The high photo stability of quantum
dots allowed the authors to pursue the
motionof singlemolecules for longperiods
of time.
Andrews et al. primed a rat basophilic
leukemia (RBL) cell line or murine bone
marrow-derived mast cells (BMMCs)
with QD-labeled IgE. The size of these
quantum dot probes is in the range of
15–20 nm, sufficiently small so as to not
create steric problems. These IgE are
specific for the antigen 2,4-dinitrophenol
(DNP), and the authors used DNP-conju-
gatedbovine serumalbumin (BSA) as their
antigen. The number of DNP molecules
per BSA was also controlled in the range
of 2–25. For a sense of the minimum anti-
gen dose used in this study, 0.001 mg/ml
of the most multivalent antigen (DNP25-
BSA) is expected to deliver 7–10 mole-
cules per 1000 mm3, which is a sufficient
number of antigen molecules to engage
many IgE-Fc receptor complexes. Diffu-
sion measurements were performed with
single-molecule imaging and tracking ofQD-IgE as a function of antigen dose.
Consistent with previous reports, with
increasing antigen concentration, IgE-
bound Fc receptors diffused more slowly
and eventually stopped (Figure 1). How-
ever, receptors exhibited substantial diffu-
sion at the lowest antigen concentration
capable of eliciting a degranulation re-
sponse. A single antigen having 25 DNP
is likely to recruit many IgE engaged re-
ceptors, perhaps not 25, but more likely
10 or fewer. To investigate the number of
IgE-Fc receptors nucleated by DNP25-
BSA, the authors exploited the unique
property of quantum dots, their narrow
emission spectrum, to demonstrate the
codiffusion of at least three different QD-
labeled IgE-Fc3RI complexes by using a
new technique that they developed call-
ed hyperspectral imaging. Therefore, a
conservative estimate is that a heavily
multivalent antigen such as DNP25-BSA
can form a signaling complex that is three
to ten receptors in size, and this complex
has the ability to signal and yet not stop
completely. This was also confirmed with
a multivalent antigen that is labeled with
quantum dots (DNP-streptavidin-QD).
The valency of this antigen is probably
similar to DNP25-BSA. DNP-streptavidin-
QD-engaged IgE-Fc3RI complexes un-
derwent substantial diffusion and had the
ability to signal; however, their diffusion
coefficient was three times slower than
an unengaged receptor.Immunity 31, SA single molecule of DNP25-BSA or QD-
streptavidin-DNP generates a complex
consisting of three to ten IgE-Fc mole-
cules and has a diffusion coefficient that
is 50%–70% lower than unengaged re-
ceptors. A lower valency antigen is likely
to diffuse more quickly and yet have a
signaling capacity. Andrews et al. show
that DNP2-BSA elicits a degranulation
response at 1 mg/ml and diffuses as quick-
ly as the unengaged receptor. They also
looked at 4 and 12 DNPs per BSA mole-
cule and observed a similar trend. Hence,
as the authors suggest, single signaling
complexes nucleated by a single antigen
molecule of different valencies have the
ability to signal without stopping com-
pletely. Higher-order complexes formed
when more than one highly multivalent
antigen involved do undergo arrest with
signaling proceeding normally. Using
electron microscopy, the authors show
that increasing antigen concentration
does produce larger sized complexes.
The difference in signaling induced by
diffusing and nondiffusing receptors is not
clear. The authors demonstrate that the
kinetics of Syk phosphorylation and cal-
cium mobilization is not very different at
different antigen doses. The only surprising
difference is the lack of Fc3RIg phosphory-
lationat lower antigendosewithout impact-
ing Syk phosphorylation. The authors dis-
cuss this discrepancy in several ways:
one, that the level of Fc3RIg phosphoryla-
tion required for Syk phosphorylation is
belowtheir detection limit; two, that the tails
of gamma chain are anchored to the
plasma membrane and are released upon
receptor crosslinking sufficient for transient
Syk recruitmentwithoutgettingphosphory-
lated; or three, that there are phosphatases
that rapidly dephosphorylate the gamma
chain. Regardless, in the future it would
be interesting to investigate with gene-
array analysis the differences in transcripts
generated in response to signaling via
diffusing and nondiffusing receptors. In
this context, it would also be interesting to
see whether cytokinergic IgE molecules
that do not require antigen to signal do so
without immobilization and whether the
low-valency DNP-BSA would serve as
amodel system to study signaling via cyto-
kinergic IgEs.
Two other observations wrap up this
study. One is that there is no bystander
effect observed with regards to immobili-
zation of receptors; only antigen-engagedeptember 18, 2009 ª2009 Elsevier Inc. 453
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coefficient. This was demonstrated by
labeling cells with IgEs with different
specificities (dansyl and DNP). Antigen-
containing DNP could not cause a change
in diffusion of IgE specific for Dansyl. The
second observation they made was that
cells treated with inhibitors of Src family
kinases showed no change in the as-
sembly of signaling complexes or their
diffusion characteristics. This result is
very similar to what has been observed
for TCR microclusters; however, the
same may not be true for BCR signaling
(Fleire et al., 2006; Tolar et al., 2005).
The data presented here have impor-
tant implications in understanding sig-
naling via ITAM-containing receptors in
the immune system. TCR and BCR under-Before They Were
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Gut lamina propria dendritic cell (DC
(2009) and Bogunovic et al. (2009
subsets.
How the intestine can tolerate trillions of
intestinal bacteria, initiate tolerance to-
ward food antigens, and fight infections
is the subject of an intense area of re-
search. Recent advances have high-
lighted a fundamental role of dendritic
cells (DCs) in these functions. In the
mouse lamina propria (LP), DCs are char-
acterized by the high expression of
CD11c and can be distinguished based
on the expression of the integrin CD103,
which recognizes E-cadherin. CD103+
DCs can drive the differentiation of T regu-
latory (Treg) cells, the effectors of toler-
ance, via a mechanism that is mediated
by retinoic acid (RA) and TGF-b (Sun
et al., 2007). In contrast, CD103 DCs
can be subdivided into two subsets. One
subset expresses CX3CR1 and drives
the development of T helper 17 (Th17)
cells (Atarashi et al., 2008). The other
454 Immunity 31, September 18, 2009 ª200go microcluster formation upon encoun-
tering antigen and is also the site where
antigen accumulates. This paper raises
the possibility that transient interactions
between antigen receptors and their
ligands outside of microclusters that do
not cause receptor clustering or immobili-
zation may still generate signals or that
microcluster formation succeeds such
transient interactions. In the future, prog-
ress in imaging technology and computer
modeling of microscopy data is likely to
illuminate this world of signaling.
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) subsets have specialized functions.
) describe the different blood precu
subset expresses the Toll-like receptor 5
(TLR5) and drives the differentiation of
both Th17 cells and IgA class-switched
B cells (Uematsu et al., 2008). However,
it was not clear whether these DCs re-
presented different activation states of
the same subset (expressing or not the
CD103) or whether they represented two
different subsets arising from distinct
blood precursors.
In this issue of Immunity, two indepen-
dent reports by Varol et al. (2009) and
Bogunovic et al. (2009) describe that the
CD103+ and CD103 DC subsets are fur-
ther distinguishable based on the expres-
sion of CD11b and CX3CR1 and derive
from different bone marrow precursors.
By using very elegant model systems
based on conditional ablation of DCs
and engraftment with defined DC precur-
sors, the two groups demonstrate that a
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In this issue of Immunity, Varol et al.
rsors for CD103+ and CD103 DC
common macrophage and DC precursor
(MDP) can give rise to both CD103+ and
CD103 DCs, whereas pre-DCs or mono-
cytes can differentiate only into CD103+ or
CD103 DCs, respectively (Figure 1).
These studies also describe the different
requirements of growth factors for the
differentiation of the two major DC sub-
sets. Both reports show a common re-
quirement of Flt3L for the differentiation
of CD11b+CD103+ and CD11bCD103+
DCs whereas Varol et al. (2009) show
that GM-CSF seems to be more involved
in the differentiation of CD11b+ (mostly
CD103) DCs. In contrast, Bogunovic
et al. (2009) find that GM-CSFR expres-
sion is dispensable for CD103 DC differ-
entiation, whereas it is required for the
differentiation of CD11b+CD103+ and
CD11bCD103+ DCs. Bogunovic et al.
(2009) also demonstrate a requirement
